(XAR) SPDR S&P Aerospace & Defense - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A6313 • Industrials
XAR: Aircraft, Defense, Space, Technology, Systems, Equipment
The SPDR S&P Aerospace & Defense ETF, listed on the NYSE ARCA under the ticker XAR, is designed to replicate the performance of the S&P Aerospace & Defense Select Industry Index. To achieve this, the fund utilizes a sampling strategy, where it invests a significant portion, typically at least 80%, of its total assets in the securities that comprise the index. This index, in turn, is a subset of the broader S&P Total Market Index, focusing specifically on the aerospace and defense sector. By tracking this particular segment, the ETF provides investors with exposure to a range of companies involved in the development, manufacture, and support of aerospace and defense equipment and services.
As an exchange-traded fund (ETF), XAR offers a diversified portfolio that includes a variety of aerospace and defense companies, potentially reducing risk through this broad exposure. The fund's holdings may encompass manufacturers of military aircraft, defense electronics, and space equipment, as well as providers of related services. With its primary listing in the United States and an ISIN of US78464A6313, the SPDR S&P Aerospace & Defense ETF is classified as an industrials ETF, reflecting its focus on this specific industrial sector. For more information, investors can visit the fund's website at http://www.spdrs.com, which provides detailed insights into the ETF's composition, performance, and investment strategy.
Investing in the SPDR S&P Aerospace & Defense ETF can provide a convenient way for investors to gain exposure to the aerospace and defense industry, which is critical for national security and has the potential for long-term growth driven by technological advancements and geopolitical factors. The fund's structure allows it to be traded like a stock on the NYSE ARCA, offering flexibility and transparency. By tracking a specific index, XAR aims to deliver returns that closely mirror the performance of the aerospace and defense segment of the S&P Total Market Index, making it a targeted investment option for those interested in this sector.
Additional Sources for XAR ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XAR ETF Overview
Market Cap in USD | 2,638m |
Category | Industrials |
TER | 0.35% |
IPO / Inception | 2011-09-28 |
XAR ETF Ratings
Growth 5y | 59.6% |
Fundamental | - |
Dividend | 47.9% |
Rel. Strength Industry | 49.9 |
Analysts | - |
Fair Price Momentum | 183.51 USD |
Fair Price DCF | - |
XAR Dividends
Dividend Yield 12m | 0.61% |
Yield on Cost 5y | 0.98% |
Annual Growth 5y | 8.85% |
Payout Consistency | 81.2% |
XAR Growth Ratios
Growth Correlation 3m | 51% |
Growth Correlation 12m | 96% |
Growth Correlation 5y | 69.6% |
CAGR 5y | 10.16% |
CAGR/Mean DD 5y | 0.83 |
Sharpe Ratio 12m | 1.65 |
Alpha | 8.63 |
Beta | 1.18 |
Volatility | 20.19% |
Current Volume | 252.8k |
Average Volume 20d | 127.7k |
As of January 22, 2025, the stock is trading at USD 180.76 with a total of 252,800 shares traded.
Over the past week, the price has changed by +7.32%, over one month by +9.07%, over three months by +10.64% and over the past year by +38.83%.
Partly, yes. Based on ValueRay Analyses, SPDR S&P Aerospace & Defense (NYSE ARCA:XAR) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.64 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XAR as of January 2025 is 183.51. This means that XAR is currently overvalued and has a potential downside of 1.52%.
SPDR S&P Aerospace & Defense has no consensus analysts rating.
According to ValueRays Forecast Model, XAR SPDR S&P Aerospace & Defense will be worth about 205.2 in January 2026. The stock is currently trading at 180.76. This means that the stock has a potential upside of +13.54%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 205.2 | 13.5% |